Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe (MTP)
Primary Purpose
Osteoarthritis
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Meniscal Allograft
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring allograft, great toe
Eligibility Criteria
Inclusion Criteria:
- symptomatic of stage 3 osteoarthritis of the great toe
- symptoms recalcitrant to nonoperative management as determined clinically by the principal investigator
Exclusion Criteria:
- diabetes mellitus
- kidney insufficiency
- oa in the adjacent joints
- malignancy with in the past 10 yrs
- minors (< 18 yrs of age)
- pregnant women and fetus
- mentally disabled or cognitively impaired individuals
Sites / Locations
- William Beaumont Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
MENISCAL ALLOGRAFT
Arm Description
The meniscal allograft is taken from the meniscal knee joint and implanted surgically in to the great toe.
Outcomes
Primary Outcome Measures
Allograft Stability
Evaluation of the MTP joint space as determined by radiographic imaging. Count of participants maintaining adequate spacing and alignment as evaluated by the surgeon.
Secondary Outcome Measures
Pain
Pain scored on Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Range of Motion Plantarflexion
Range of Motion Plantarflexion
Range of Motion Dorsiflexion
Range of Motion Dorsiflexion
Full Information
NCT ID
NCT01673347
First Posted
August 14, 2012
Last Updated
April 19, 2017
Sponsor
Paul Fortin, MD
Collaborators
Musculoskeletal Transplant Foundation
1. Study Identification
Unique Protocol Identification Number
NCT01673347
Brief Title
Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe
Acronym
MTP
Official Title
Allograft Knee Meniscal Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
September 2010 (Actual)
Primary Completion Date
May 2014 (Actual)
Study Completion Date
March 10, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Paul Fortin, MD
Collaborators
Musculoskeletal Transplant Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Using the concept of an implant acting as a spacer and stabilizer, the proposed study will evaluate the use of allograft knee meniscus in the treatment of MTP joint osteoarthritis of the great toe.
Detailed Description
A variety of surgical procedures have been developed for the treatment of MTP joint osteoarthritis of the great toe. Using the concept of an implant acting as a spacer and stabilizer, the proposed study will evaluate the use of allograft knee meniscus in the treatment of MTP joint osteoarthritis of the great toe. Patients will be evaluated for pain and range of motion at 3-months, 6-months, 1-year, 2-years, 3-years, 4-years, and 5-years postoperatively or until allograft failure. Stability of the allograft will be evaluated by the surgeon at these time points per radiographic imaging.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
allograft, great toe
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
MENISCAL ALLOGRAFT
Arm Type
Experimental
Arm Description
The meniscal allograft is taken from the meniscal knee joint and implanted surgically in to the great toe.
Intervention Type
Biological
Intervention Name(s)
Meniscal Allograft
Other Intervention Name(s)
Musculoskeletal Transplant Foundation, Meniscal transplant
Intervention Description
Meniscal allograft
Primary Outcome Measure Information:
Title
Allograft Stability
Description
Evaluation of the MTP joint space as determined by radiographic imaging. Count of participants maintaining adequate spacing and alignment as evaluated by the surgeon.
Time Frame
5-years postoperative
Secondary Outcome Measure Information:
Title
Pain
Description
Pain scored on Visual Analog Scale 0-10; 0 = no pain, 10 = worst pain
Time Frame
3-months postoperative
Title
Range of Motion Plantarflexion
Description
Range of Motion Plantarflexion
Time Frame
3-months postoperative
Title
Range of Motion Dorsiflexion
Description
Range of Motion Dorsiflexion
Time Frame
3-months postoperative
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
symptomatic of stage 3 osteoarthritis of the great toe
symptoms recalcitrant to nonoperative management as determined clinically by the principal investigator
Exclusion Criteria:
diabetes mellitus
kidney insufficiency
oa in the adjacent joints
malignancy with in the past 10 yrs
minors (< 18 yrs of age)
pregnant women and fetus
mentally disabled or cognitively impaired individuals
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
PAUL FORTIN, MD
Organizational Affiliation
WILLIAM BEAUMONT HOSPITAL ROYAL OAK
Official's Role
Principal Investigator
Facility Information:
Facility Name
William Beaumont Hospital
City
Royal Oak
State/Province
Michigan
ZIP/Postal Code
48073
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
Citation
COLE BJ, CARTER TR, RODEO SA,
Results Reference
background
Links:
URL
http://beaumonthospitals.com
Description
Beaumont Hospital
Learn more about this trial
Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe
We'll reach out to this number within 24 hrs